GAD1 and type 2 diabetes mellitus: Given the trend in GAD antibody titers and other negative islet-associated autoantibodies, in addition to the absence of insulin secretory deficiency, our patient was diagnosed with type 2 diabetes, not type 1 diabetes mellitus, such as slowly progressive insulin-dependent diabetes mellitus (SPIDDM).